We at Aesthetics International have carefully selected a number of our clinically proven office procedures so as to be able to offer discreet treatment, conveniently located in the city's central locations. Led by one of Dubai's most renowned cosmetic surgeons, our team of experts are based permanently at our specially designed clinic.
Health & Personal Care
WeRema engaged in Healthcare and medical Equipment. Our strong network of distribution facilities with particular emphasis on production design
Welcome to DBSouq.com - Your one-stop-destination for anything and everything online in the Middle East! Before we get you apprised of about who we are and what we intend to do, let's take you through our ubiquitous online shopping website offering products in a diverse range of categories for men, women, kids and your other needs as well as services also. Through this, let us get you acquainted with this trend called online shopping or e-shopping.
Intimate Hygiene, Health And Hygiene
Hoventa Pharma is in the business of manufacturing APIs for over three decades.We offer various kinds of services in addition to supplies of APIs, we undertake long-term contracts for manufacturing intermediates and development of new Active Pharmaceutical Ingredients as per your requirement. We have a sharp focus on giving value added services to our customers cost effectively.
We are supplying APIs to the global pharmaceutical companies in India and abroad since the last 3 decades. Some of our major customers operate in India and export to their products to other countries. Our customers like Teva Pharmaceuticals, Jubilant, Glenmark, Hetero Drugs, Macleod, Abbott, FDC, Wallace Pharma, Intas Pharmaceuticals, Cipla, Aristo pharmaceuticals.
Founded in 1995 with a vision to establish a company that would in turn help create a healthier China, Simcere Pharmaceutical Group has become a leading manufacturer and supplier of drugs in the rapidly growing China pharmaceutical market, we now have seven certified Good Manufacturing Practices ("GMP") manufacturing facilities and three research and development center and over 4,000 employees. Now Simcere has more than 20 Innovative Pharmaceuticals which are under development, and they all have independent intellectual property rights. In 2010, From them we submitted five clinical trial applications to the SFDA.
In 2007 Simcere successfully landed the New York Stock Exchange (ticker symbol SCR) as the first one in mainland China's chemical and biological drugs NYSE-listed company.